Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.

Cell stem cell | Nov 5, 2010

http://www.ncbi.nlm.nih.gov/pubmed/20888316

Clinical application of induced pluripotent stem cells (iPSCs) is limited by the low efficiency of iPSC derivation and the fact that most protocols modify the genome to effect cellular reprogramming. Moreover, safe and effective means of directing the fate of patient-specific iPSCs toward clinically useful cell types are lacking. Here we describe a simple, nonintegrating strategy for reprogramming cell fate based on administration of synthetic mRNA modified to overcome innate antiviral responses. We show that this approach can reprogram multiple human cell types to pluripotency with efficiencies that greatly surpass established protocols. We further show that the same technology can be used to efficiently direct the differentiation of RNA-induced pluripotent stem cells (RiPSCs) into terminally differentiated myogenic cells. This technology represents a safe, efficient strategy for somatic cell reprogramming and directing cell fate that has broad applicability for basic research, disease modeling, and regenerative medicine.

Pubmed ID: 20888316 RIS Download

Mesh terms: Cell Differentiation | Cell Lineage | Cells, Cultured | Cellular Reprogramming | Humans | Induced Pluripotent Stem Cells | RNA, Messenger

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIDCR NIH HHS, Id: RL1 DE019021
  • Agency: NIDCR NIH HHS, Id: RL1DE01902
  • Agency: NHLBI NIH HHS, Id: U01 HL100001
  • Agency: Howard Hughes Medical Institute, Id:
  • Agency: Howard Hughes Medical Institute, Id:

Cellosaurus (Reagent, Cell Line)

Addgene (Reagent, Plasmid)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.